# US 2025/0027143 A1 · Detecting polynucleotides with barcoded oligonucleotide probes

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2025/0027143 A1
- Document ID: US20250027143A1
- Status: Published application
- Kind: A1
- Application number: 18/889,834
- Filed: 2024-09-19
- Published: 2025-01-23
- Earliest claimed: 2019-12-31
- Assignees: Singular Genomics Systems, Inc.
- Applicants: Singular Genomics Systems, Inc.
- Inventors: Eli N. Glezer; Martin Maria Fabani; Ryan Shultzaberger; Bharat Sridhar; Gudrun Stengel; Christopher Jen-Yue Wei
- Web page: https://patentgrep.com/patent/US20250027143A1

## CPC

- C12Q 1/6853: using modified primers or templates
- C12Q 1/6869: Methods for sequencing
- C12Q: MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS (immunoassay G01N33/53); COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES

## Abstract

Provided herein are methods of detecting polynucleotides with a set of barcoded oligonucleotide probes.

## Claims

### Claim 1

A method of sequencing, said method comprising:
contacting a sample with a set of barcoded probes, wherein the set of barcoded probes comprises a first oligonucleotide probe comprising a first target hybridization sequence and a first barcode sequence; a second oligonucleotide probe comprising a second target hybridization sequence and a second barcode sequence; and a third oligonucleotide probe comprising a third target hybridization sequence and a third barcode sequence; wherein each target hybridization sequence specifically binds to a different sequence of a target polynucleotide;
binding the set of barcoded probes to the sample, wherein the sample comprises one or more target polynucleotides;
sequencing each barcode sequence of the set of barcoded probes; and
identifying the polynucleotide in the sample based on the sequenced barcode sequences of the set of barcoded probes.

### Claim 2 (depends on 1)

The method of claim 1, wherein sequencing generates a sequencing read for each barcode sequence.

### Claim 3 (depends on 1)

The method of claim 1, wherein prior to sequencing the barcode sequences, the method comprises amplifying the barcode sequences and forming amplification products, and sequencing the amplification products.

### Claim 4 (depends on 2)

The method of claim 2, wherein sequencing produces a plurality of sequencing reads, the method further comprises computationally grouping the plurality of sequencing reads based on the co-occurrence of the barcode sequences in the set of barcoded probes.

### Claim 5 (depends on 2)

The method of claim 2, wherein sequencing comprises sequencing-by synthesis (SBS), pyrosequencing, sequencing by ligation (SBL), or sequencing by hybridization (SBH).

### Claim 6 (depends on 1)

The method of claim 1, wherein each barcode sequence comprises about 5 to about 20 nucleotides.

### Claim 7 (depends on 1)

The method of claim 1, wherein each barcode sequence comprises 10 to 16 nucleotides.

### Claim 8 (depends on 1)

The method of claim 1, wherein each barcode sequence differs from every other barcode sequence by at least two nucleotide positions.

### Claim 9 (depends on 1)

The method of claim 1, wherein the target polynucleotide comprises a cancer-associated gene, T cell receptor (TCR) gene, or a B cell receptor (BCR) gene.

### Claim 10 (depends on 9)

The method of claim 9, wherein the cancer-associated gene is an ALK gene, BCL2 gene, HER2 gene, MYC gene, KRAS gene, MMP-10 gene, VEGF-D gene, PlGF gene, or P-Cadherin gene.

### Claim 11 (depends on 9)

The method of claim 9, wherein the TCR gene is a TCR alpha (TCRA) chain, a TCR beta (TCRB) chain, or a TCR delta (TCRD) chain.

### Claim 12 (depends on 9)

The method of claim 9, wherein the TCR gene is a TCRA gene or a TCRB gene.

### Claim 13 (depends on 1)

The method of claim 1, wherein the target polynucleotide is messenger RNA (mRNA).

### Claim 14 (depends on 13)

The method of claim 13, wherein the sample comprises a plurality of mRNA molecules.

### Claim 15 (depends on 1)

The method of claim 1, wherein the sample comprises cells or tissues.

### Claim 16 (depends on 15)

The method of claim 15, wherein the cells are cancer cells.

### Claim 17 (depends on 1)

The method of claim 1, further comprising:
contacting the sample with a second set of barcoded probes, wherein the second set of barcoded probes comprises a fourth oligonucleotide probe comprising a fourth target hybridization sequence and a fourth barcode sequence; a fifth oligonucleotide probe comprising a fifth target hybridization sequence and a fifth barcode sequence; and a sixth oligonucleotide probe comprising a sixth target hybridization sequence and a sixth barcode sequence; wherein each target hybridization sequence specifically binds to a different sequence of a second target polynucleotide;
binding the second set of barcoded probes to the sample;
sequencing each barcode sequence of the second set of barcoded probes; and
identifying the polynucleotide in the sample based on the sequenced barcode sequences of the second set of barcoded probes.

### Claim 18 (depends on 17)

The method of claim 17, wherein the second target polynucleotide comprises an ABL1, AKT1, ALK, APC, ATM, BRAF, CDH1, CDKN2A, CSF1R, CTNNB1, EGFR, ERBB2, ERBB4, EZH2, FBXW7, FGFR1, FGFR2, FGFR3, FLT3, GNA11, GNAQ, GNAS, HRAS, IDH1, IDH2, JAK2, JAK3, KDR, KIT, KRAS, MET, MLH1, MPL, NOTCH1, NPM1, NRAS, PDGFRA, PIK3CA, PTEN, PTPN11, RB1, RET, SMAD4, SMARCB1, SMO, SRC, STK11, TP53, or VHL gene.

### Claim 19 (depends on 1)

The method of claim 1, wherein each oligonucleotide probe of the set comprises a sequence common to all of the oligonucleotide probes in the set.

### Claim 20 (depends on 1)

The method of claim 1, wherein the set of barcoded probes comprises 6 to 12 oligonucleotide probes comprising a barcode sequence.
